1. Home >
  2. M&A >
  3. Divestiture >
  4. United States >
  5. Florida >
  6. Lindora Acquires Zerona Z6

M&A Deal Summary

Lindora Acquires Zerona Z6

On October 3, 2019, Lindora acquired healthcare services company Zerona Z6 from Erchonia

Acquisition Highlights
  • This is Lindora’s 1st transaction in the Healthcare Services sector.
  • This is Lindora’s 1st transaction in the United States.
  • This is Lindora’s 1st transaction in Florida.

M&A Deal Summary
Date 2019-10-03
Target Zerona Z6
Sector Healthcare Services
Buyer(s) Lindora
Sellers(s) Erchonia
Deal Type Divestiture

Target

Zerona Z6

Melbourne, Florida, United States
Zerona Z6 is a full body fat loss treatment that allows clients to target areas of stubborn fat and is the first laser specifically designed for body contouring. The technology is FDA Market-Cleared, non-invasive and clinically tested. Zerona Z6 provides an alternative fat loss treatment without the adverse side effects associated with surgical and other weight loss procedures like liposuction and body wraps.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Lindora

Irvine, California, United States
Category Company
Founded 1971
Sector Consumer Services
DESCRIPTION

Lindora is a provider of comprehensive, medically-based weight loss treatments and products. Lindora operates 35 stand-alone clinics across Southern California and seven in-store clinics in selected Rite Aid stores. Lindora was founded in 1971 and is based in Irvine, California.

DEAL STATS #
Overall 1 of 1
Sector: Healthcare Services M&A 1 of 1
Type: Divestiture M&A Deals 1 of 1
State: Florida M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2019 M&A 1 of 1

Seller(S) 1

SELLER

Erchonia

Melbourne, Florida, United States
Category Company
Founded 1996
Sector Healthcare Services
DESCRIPTION

Erchonia Corp. is the only company with low-level lasers that were market cleared by the FDA for use with low back pain, onychomycosis, plantar fasciitis, and many other issues. Erchonia has remained committed to furthering the advancement of low-level laser therapy (LLLT) through scientific and clinical studies and the development of FDA Market Cleared lasers.

DEAL STATS #
Overall 1 of 1
Sector: Healthcare Services M&A 1 of 1
Type: Divestiture M&A Deals 1 of 1
State: Florida M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2019 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal